ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Review Process A Disaster, Borek Says

October 19, 1979

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974

Quality of Care: ASCO Publishes “Top Five” Ways to Improve Cancer Care

November 1, 2013

Toxicity, Non-Cancer Deaths Increase With Combo Therapy

July 30, 2010

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

Other Institutes Fare Well With ’77 Appropriations

August 20, 1976